Delfi Diagnostics

Delfi Diagnostics company information, Employees & Contact Information

DELFI uses artificial intelligence and whole genome sequencing to sensitively detect unique patterns of DNA fragmentation in the blood of patients with cancer.

Company Details

Employees
180
Founded
-
Address
2809 Boston St,
Phone
410-696-3304
Email
in****@****ics.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
firms.
HQ
Baltimore, Maryland
Looking for a particular Delfi Diagnostics employee's phone or email?

Delfi Diagnostics Questions

News

DELFI Diagnostics CTO Recognized among 2025 Most Influential Women in Bay Area Business - PR Newswire

DELFI Diagnostics CTO Recognized among 2025 Most Influential Women in Bay Area Business PR Newswire

DELFI Diagnostics to Participate in J.P. Morgan Healthcare Conference - PR Newswire

DELFI Diagnostics to Participate in J.P. Morgan Healthcare Conference PR Newswire

2025 Best Startup Businesses in Maryland: DELFI Diagnostics - Maryland Daily Record

2025 Best Startup Businesses in Maryland: DELFI Diagnostics Maryland Daily Record

DELFI Diagnostics Appoints Thomas Russo as Chief Financial Officer - citybiz

DELFI Diagnostics Appoints Thomas Russo as Chief Financial Officer citybiz

Allegheny Health Network explores use of promising new blood-based test to enhance lung cancer detection - PRWeb

Allegheny Health Network explores use of promising new blood-based test to enhance lung cancer detection PRWeb

Delfi Diagnostics Announces $225 Million in Series B - The SaaS News

Delfi Diagnostics Announces $225 Million in Series B The SaaS News

DELFI Diagnostics Names Dr. Amoolya Singh as Chief Technology Officer - PR Newswire

DELFI Diagnostics Names Dr. Amoolya Singh as Chief Technology Officer PR Newswire

DELFI Diagnostics Selects Lahey Hospital & Medical Center to Administer New Lung Cancer Screening Test - PR Newswire

DELFI Diagnostics Selects Lahey Hospital & Medical Center to Administer New Lung Cancer Screening Test PR Newswire

DELFI Diagnostics Names Robert Guigley as Chief Commercial Officer to Expand Access to Early Cancer Screening - PR Newswire

DELFI Diagnostics Names Robert Guigley as Chief Commercial Officer to Expand Access to Early Cancer Screening PR Newswire

DELFI Diagnostics Appoints Susan Tousi as New Chief Executive Officer - PR Newswire

DELFI Diagnostics Appoints Susan Tousi as New Chief Executive Officer PR Newswire

DELFI Diagnostics Study on Cancer Treatment Monitoring Using Fragmentomes Featured in Nature Communications - PR Newswire

DELFI Diagnostics Study on Cancer Treatment Monitoring Using Fragmentomes Featured in Nature Communications PR Newswire

OSF HealthCare and DELFI Diagnostics Announce Collaboration to Improve Lung Cancer Screening Rates - PR Newswire

OSF HealthCare and DELFI Diagnostics Announce Collaboration to Improve Lung Cancer Screening Rates PR Newswire

Florida Lung Health Coalition, with Support from DELFI Diagnostics, RadNet, Inc., and The American Lung Association, to Launch a Revolutionary Lung Cancer Screening Program Focused on Early Detection - PR Newswire

Florida Lung Health Coalition, with Support from DELFI Diagnostics, RadNet, Inc., and The American Lung Association, to Launch a Revolutionary Lung Cancer Screening Program Focused on Early Detection PR Newswire

DELFI Diagnostics Announces Availability of New Fragmentome-Based Cancer Treatment Monitoring Assay - PR Newswire

DELFI Diagnostics Announces Availability of New Fragmentome-Based Cancer Treatment Monitoring Assay PR Newswire

DELFI Diagnostics Announces Equity Investment from the Merck Global Health Innovation Fund to Accelerate DELFI's Cancer Screening AI Fragmentomics Platform - PR Newswire

DELFI Diagnostics Announces Equity Investment from the Merck Global Health Innovation Fund to Accelerate DELFI's Cancer Screening AI Fragmentomics Platform PR Newswire

City of Hope and DELFI Diagnostics announce collaboration to improve lung cancer screening rates in underserved areas of Los Angeles - PR Newswire

City of Hope and DELFI Diagnostics announce collaboration to improve lung cancer screening rates in underserved areas of Los Angeles PR Newswire

Indigenous Pact and DELFI Diagnostics Join Forces to Enhance Lung Cancer Screening in Tribal Communities - PR Newswire

Indigenous Pact and DELFI Diagnostics Join Forces to Enhance Lung Cancer Screening in Tribal Communities PR Newswire

Doug Schenkel Joins Delfi Diagnostics as Chief Financial Officer - PR Newswire

Doug Schenkel Joins Delfi Diagnostics as Chief Financial Officer PR Newswire

Delfi Bolsters Leadership Team with Three Key Hires - PR Newswire

Delfi Bolsters Leadership Team with Three Key Hires PR Newswire

Landmark Blood-Based AI Lung Cancer Screening Test Study Results Published in Cancer Discovery - PR Newswire

Landmark Blood-Based AI Lung Cancer Screening Test Study Results Published in Cancer Discovery PR Newswire

DELFI Diagnostics to Present at American Association for Cancer Research Annual Meeting - PR Newswire

DELFI Diagnostics to Present at American Association for Cancer Research Annual Meeting PR Newswire

Delfi Diagnostics announces key data, study design for its liquid biopsy test - statnews.com

Delfi Diagnostics announces key data, study design for its liquid biopsy test statnews.com

DELFI Diagnostics to Highlight Breakthrough Technology and Completed Clinical Study in Lung Cancer Detection - PR Newswire

DELFI Diagnostics to Highlight Breakthrough Technology and Completed Clinical Study in Lung Cancer Detection PR Newswire

DELFI Diagnostics Launches FirstLook Lung, an Accessible, Accurate New Way to Enhance Lung Cancer Screening Through a Routine Blood Test - PR Newswire

DELFI Diagnostics Launches FirstLook Lung, an Accessible, Accurate New Way to Enhance Lung Cancer Screening Through a Routine Blood Test PR Newswire

DELFI Diagnostics Licenses GEMINI Technology from Johns Hopkins University: Study Demonstrates High Performance for Early Stage Lung Cancer Detection When Integrated with DELFI Diagnostics's Platform - PR Newswire

DELFI Diagnostics Licenses GEMINI Technology from Johns Hopkins University: Study Demonstrates High Performance for Early Stage Lung Cancer Detection When Integrated with DELFI Diagnostics's Platform PR Newswire

Delfi Diagnostics Initiates 15,000-Patient Prospective Lung Cancer Screening Trial - PR Newswire

Delfi Diagnostics Initiates 15,000-Patient Prospective Lung Cancer Screening Trial PR Newswire

Delfi Diagnostics Adds Reimbursement, Regulatory Leaders to Management Team - PR Newswire

Delfi Diagnostics Adds Reimbursement, Regulatory Leaders to Management Team PR Newswire

Delfi Diagnostics launches blood-based lung cancer screening test - Fierce Biotech

Delfi Diagnostics launches blood-based lung cancer screening test Fierce Biotech

Delfi Diagnostics scoops up $225M from Lilly, Illumina and more for its cancer blood tests - Fierce Biotech

Delfi Diagnostics scoops up $225M from Lilly, Illumina and more for its cancer blood tests Fierce Biotech

Delfi Diagnostics raises $100M for a new approach to screening blood for cancer - Fierce Biotech

Delfi Diagnostics raises $100M for a new approach to screening blood for cancer Fierce Biotech

Delfi Diagnostics Appoints Liz Homans to its Board of Directors - PR Newswire

Delfi Diagnostics Appoints Liz Homans to its Board of Directors PR Newswire

Delfi Diagnostics' AI-based blood test detects 80% of early-stage lung cancer cases, study finds - Fierce Biotech

Delfi Diagnostics' AI-based blood test detects 80% of early-stage lung cancer cases, study finds Fierce Biotech

Top Delfi Diagnostics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant